Last reviewed · How we verify

NCT05652218: REINVENT

REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT)

Active, enrolled NA Last updated 2 January 2026
What this trial tests

NA trial testing LB-CRT in Left Ventricular Ejection Fraction in 21 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
26 February 2023
Primary endpoint
28 February 2026
31 March 2026

Quick facts

Lead sponsorInova Health Care Services
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposeother
Enrollment21
Start date26 February 2023
Primary completion28 February 2026
Estimated completion31 March 2026
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Inova Health Care Services — full company profile →

Who can join

Eligibility, any sex, with Left Ventricular Ejection Fraction or Heart Failure (HF). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Primary Objective - To determine if implantation of a permanent CRT pacing device (with LB-CRT, or conventional BiV-CRT with a coronary sinus LV lead) can improve electromechanical function, HF symptoms, and natriuretic peptide levels among patients with symptomatic HF, LVEF \> 35%, and LBBB.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Cardiac Resynchronization Therapy and Conduction System Pacing.
    O'Neill TG, Tsushima T, Tayal B. · · 2025 · cited 1× · PMID 40364243 · DOI 10.3390/jcm14093212
  2. Conduction System Pacing for Heart Failure.
    Smith NR, Lynch P, Chelu MG. · · 2024 · PMID 39677397 · DOI 10.14503/thij-24-8469

Verify or expand the search:

Other Inova Health Care Services trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05652218.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing